Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Mirati_Therapeutics,_Inc.
|
| gptkbp:acquisition |
Glyco Mimetics, Inc. acquired by a larger pharmaceutical company
|
| gptkbp:awards |
industry recognition awards
|
| gptkbp:business_model |
licensing agreements
biopharmaceutical development commercialization of drugs |
| gptkbp:ceo |
gptkb:Rachel_King
|
| gptkbp:clinical_trial |
Phase 3 trials
ongoing clinical trials Phase 1 trials Phase 2 trials GMI-1070 for sickle cell disease GMI-1271 GMI-1271 for AML GMI-1359 for cancer |
| gptkbp:collaborations |
academic institutions
biopharmaceutical companies |
| gptkbp:community_engagement |
patient advocacy groups
|
| gptkbp:employees |
approximately 50
|
| gptkbp:financial_performance |
quarterly earnings reports
|
| gptkbp:focus |
glycomimetic drugs
|
| gptkbp:focus_area |
gptkb:healthcare_organization
gptkb:sickle_cell_disease other hematological malignancies |
| gptkbp:founded |
gptkb:2003
|
| gptkbp:future_plans |
enhance research capabilities
expand product pipeline develop new therapies increase clinical trial activities |
| gptkbp:headquarters |
gptkb:Rockville,_Maryland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Glyco Mimetics, Inc.
|
| gptkbp:invention |
multiple patents in glycomimetics
|
| gptkbp:investment |
oncology
hematology Venture capital firms investor presentations |
| gptkbp:leadership |
experienced management team
|
| gptkbp:mission |
improve patient outcomes
|
| gptkbp:partnership |
gptkb:healthcare_organization
|
| gptkbp:partnerships |
research institutions
international collaborations clinical research organizations pharmaceutical collaborations |
| gptkbp:products |
GMI-1070
GMI-1359 |
| gptkbp:publishes |
peer-reviewed journals
|
| gptkbp:receives_funding_from |
public offerings
private placements grants from government agencies collaborative research funding |
| gptkbp:regulatory_compliance |
FDA approval process
|
| gptkbp:research_areas |
gptkb:healthcare_organization
|
| gptkbp:research_focus |
drug discovery
therapeutic development glycan mimetics |
| gptkbp:symbol |
GLYC
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:vision |
transforming the treatment of diseases
|
| gptkbp:website |
www.glycomimetics.com
|